Cita APA (7a ed.)
Graf, J., Pape, U., Jann, H., Denecke, T., Arsenic, R., Brenner, W., . . . Prasad, V. (2020). Prognostic Significance of Somatostatin Receptor Heterogeneity in Progressive Neuroendocrine Tumor Treated with Lu-177 DOTATOC or Lu-177 DOTATATE. European Journal of Nuclear Medicine & Molecular Imaging, 47(4), 881-895.
Cita Chicago Style (17a ed.)
Graf, Josephine, Ulrich-Frank Pape, Henning Jann, Timm Denecke, Ruza Arsenic, Winfried Brenner, Marianne Pavel, y Vikas Prasad. "Prognostic Significance of Somatostatin Receptor Heterogeneity in Progressive Neuroendocrine Tumor Treated with Lu-177 DOTATOC or Lu-177 DOTATATE." European Journal of Nuclear Medicine & Molecular Imaging 47, no. 4 (2020): 881-895.
Cita MLA (9a ed.)
Graf, Josephine, et al. "Prognostic Significance of Somatostatin Receptor Heterogeneity in Progressive Neuroendocrine Tumor Treated with Lu-177 DOTATOC or Lu-177 DOTATATE." European Journal of Nuclear Medicine & Molecular Imaging, vol. 47, no. 4, 2020, pp. 881-895.
Precaución: Estas citas no son 100% exactas.